KAY E GERALD 4
4 · INTEGRATED BIOPHARMA INC · Filed Nov 4, 2021
Insider Transaction Report
Form 4
KAY E GERALD
DirectorCEO and President10% Owner
Transactions
- Award
Stock Option (right to buy)
2021-11-03+65,000→ 65,000 totalExp: 2026-11-03→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]The Exercise Price of the Stock Option will be 110% of the closing price of the Issuer's Common Stock five trading days after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2021, with the Securities and Exchange Commission.
- [F2]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 3, 2022.